126 related articles for article (PubMed ID: 15128425)
1. Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome.
Urban C; Benesch M; Sovinz P; Schwinger W; Lackner H
Eur J Haematol; 2004 Jun; 72(6):444-7. PubMed ID: 15128425
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
3. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
Radhi M; Rumelhart S; Tatman D; Goldman F
J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
Rückert A; Glimm H; Lübbert M; Grüllich C
Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656
[TBL] [Abstract][Full Text] [Related]
5. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
6. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
7. Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia.
Schäppi MG; Belli DC; Rimensberger PC; Chardot C; Kaya G; Tiercy JM; Ozsahin H
Liver Transpl; 2006 Nov; 12(11):1693-7. PubMed ID: 17058230
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
10. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
11. A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT.
Goddard DS; Ruben BS; Mathes ED; Nixon M; Wolf J; Fox LP
Bone Marrow Transplant; 2010 Feb; 45(2):409-11. PubMed ID: 19597426
[No Abstract] [Full Text] [Related]
12. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
13. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review.
Lekakis LJ; Macrinici V; Baraboutis IG; Mitchell B; Howard DS
Am J Hematol; 2009 Apr; 84(4):243-6. PubMed ID: 19208419
[TBL] [Abstract][Full Text] [Related]
14. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of 2 children with mucopolysaccharidosis by allogeneic hematopoietic stem cell transplantation].
Chen J; Jiang H; Dong L; Wang Y; Luo C; Zhou M; Zhang W; Huang S; Gu X; Qiu W; Zhang H; Gu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):675-7. PubMed ID: 19065530
[TBL] [Abstract][Full Text] [Related]
16. Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML.
Rokicka M; Styczynski J; Michalewska B; Torosian T; Tomaszewska A; Gronkowska A; Pogorzala M; Wysocki M; Lakomy M; Wiktor-Jedrzejczak W
Bone Marrow Transplant; 2009 Sep; 44(6):383-5. PubMed ID: 19219078
[No Abstract] [Full Text] [Related]
17. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Sedlácek P; Formánková R; Keslová P; Srámková L; Hubácek P; Król L; Kulich M; Starý J
Bone Marrow Transplant; 2006 Dec; 38(11):745-50. PubMed ID: 17041606
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
[TBL] [Abstract][Full Text] [Related]
20. [A case of autoimmune hemolytic anemia complicating hematopoietic cell transplantation].
Chae H; Kim Y; Kim M; Lim J; Han K; Cho SG; Lee JW
Korean J Lab Med; 2008 Feb; 28(1):64-9. PubMed ID: 18309257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]